Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers.
Company Details
- Employees
- 19
- Address
- 84 Hotham St, Melbourne,victoria 3072,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sudapharma.com
- Keywords
- Biotechnology, Advanced Cell Therapy, Oncology, iNKT Cell Therapy, Invariant natural killer T (iNKT) cell therapy platform, CAR engineering, blood cancers, solid tumours.
- HQ
- Melbourne, Victoria
Arovella Therapeutics Asx: Ala Questions
Arovella Therapeutics Asx: Ala's website is sudapharma.com
Arovella Therapeutics Asx: Ala's LinkedIn profile is https://au.linkedin.com/company/arovella-therapeutics
Arovella Therapeutics Asx: Ala has
19 employees.
View email and phone details for 19
employees at Arovella Therapeutics Asx: Ala.
Arovella Therapeutics Asx: Ala's industry is
Biotechnology Research
Arovella Therapeutics Asx: Ala's top competitors are
Bcal Diagnostics,
Telix Pharmaceuticals Limited,
Hexima Limited (Asx:hxl),
Chimeric Therapeutics,
Neurizon,
Cell Therapies Pty Ltd,
Imugene Limited,
Active Biotech Ab,
Carina Biotech,
Dimerix Limited.
Arovella Therapeutics Asx: Ala's categories are Biotechnology Research
